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ABSTRACT
As the incidence of osteoarthritis and other degenerative joint conditions
continues to grow, rehabilitation via tissue engineering is becomingly increasingly
attractive as an alternative to traditional surgical interventions.
Chapters 2 and 3 of this thesis are specifically concerned with cartilage tissue
engineering, while chapter 4 is relevant to bone and osteochondral tissue engineering.
The cartilage tissue engineering sections focus on the effects of two different
classes of regulators of chondrocyte behavior: chemical growth factors and mechanical
loading. In chapter 2, FGF-2, a chemical regulator, was supplied to chondrocyte-seeded
constructs over a 4 week culture period. Afterward, these constructs were subjected to
sequential ramp and hold compressive strains on a Dynastat mechanical testing apparatus,
and the unconfined elastic moduli were calculated. These data were compared to the
values for scaffolds receiving no FGF. The results indicate that FGF-2 induced a
significant increase in the modulus of chondrocyte-seeded scaffolds.
Numerous reports indicate that certain types of mechanical loading can increase
chondrocytes' ECM biosynthesis in particular cell-scaffold systems in vitro. Few if any
loading experiments have been done, however, with type II collagen-GAG scaffolds
cultured in serum-free medium. Chapter 3 describes a series of experiments in which
chondrocyte-seeded scaffolds were subjected to dynamic compression and the effects of
this treatment on the proliferation of the chondrocytes, their synthesis of ECM, and the
stiffness of the scaffolds were measured. The results of these experiments were
inconclusive. Analysis indicated that very few chondrocytes were retained in the
scaffolds. A post hoc investigation of the scaffolds revealed that they were biologically
inactive due to their oversize pores. The low cell density was reflected in unusually low
biosynthesis values and no significant differences in stiffness post-loading.
The mechanical properties of implantable constructs such as stiffness and
compressive strength are likely to significantly affect the clinical outcome. The fourth
chapter describes measurements of the elastic modulus and ultimate compressive strength
3
of a bone scaffold material. Five different scaffold formulations were tested, and the
mechanical properties correlated with the variations in their composition.
Thesis Supervisor: Myron Spector
Title: Senior Lecturer, Department of Mechanical Engineering
Professor of Orthopaedic Surgery (Biomaterials), Harvard Medical School
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1. GENERAL INTRODUCTION
1.1 Articular Cartilage Composition, Function and Degeneration
Articular cartilage is an exquisitely tuned composite of cells (chondrocytes),
extracellular matrix (ECM) molecules, and water which sustains the tremendous forces
experienced by knees, hips and the other diarthroidal joints. (Note that ECM, scaffold,
matrix, and substrate are used interchangeably in this thesis.) The chondrocytes
manufacture and remodel the ECM which simultaneously provides the 3-dimensional
structure housing and protecting the cells as well as the mechanical integrity of cartilage.
Chondrocytes will only carry out their normal metabolic functions if they are able to
attach to a substrate; thus, the production and maintenance of the substrate (i.e., ECM)
depends on the prior existence of a substrate. We will return to this consideration later in
the section on tissue engineering.
The other primary component of cartilage, water, comprises approximately 80%
of the wet weight of cartilage. The water contains electrolytes and cations which balance
the negatively charged proteoglycans within the ECM, and this molecular interaction also
contributes to cartilage's stiffness and resilience (Temenoff and Mikos 2000).
At densities of approximately 10,000 chondroctyes/mm3 in adult humans,
cartilage is relatively acellular. It is, furthermore, completely lacking in vascular
connection; thus, chondrocytes rely on diffusion from the synovial fluid within the joint
capsule through the dense ECM for their nutrient supply and waste removal (Buckwalter
1998). Due to its low metabolic activity and proliferation (for many years it was believed
that chondrocytes, like nerve cells, do not reproduce at all), damage to cartilage -
whether through disease or acute trauma - generally does not heal. Thus for millions of
osteoarthritis patients, the prognosis is usually poor: increasing pain and decreasing joint
function as focal lesions expand into the neighboring healthy cartilage.
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1.2 Cartilage Repair: Traditional Approaches
Numerous techniques for treating damaged joints have been proposed. Although
some studies have shown a reduction in pain after certain superficial treatments, there is
little evidence that such treatments actually improve the condition of the cartilage. One
class of these treatments currently in use involves little more than arthroscopic lavage of
the joint and/or removal of fibrillated tissue (Kim, Moran et al. 1991; Altman, Kates et al.
1992). In osteotomy, a more invasive procedure, the tibia or femur (in the case of
damage to the knee) is surgically reshaped, realigning the axis of the limb away from the
diseased area. In severe cases either part or the entire joint may be surgically replaced by
unicompartmental joint arthroplasty or total joint arthroplasty (TJA), respectively
{AAOS Online, 2001 #196}.
Recognizing the critical role of the extracellular matrix, other interventions
endeavor to create a natural matrix by penetrating the subchondral bone, inducing clot
formation from blood which then flows into the defect from the marrow space.
Numerous techniques exist for creating these penetrations. Another treatment, referred to
as mosaicplasty, is the transplantation of autologous cartilage from non-weight bearing
sections of a damaged joint to the weight bearing sections that are more critical to joint
function and biomechanical load transfer (Buckwalter 1998; Buckwalter 1998). In
contrast to transplanting cartilage plugs as in mosaicplasty, in autologous chondrocyte
transplantation cells are excised and allowed to multiply in vitro and then implanted
(usually under a periosteal flap) in the cartilage defect (Brittberg, Lindahl et al. 1994;
Brittberg, Nilsson et al. 1996; Breinan, Minas et al. 1997; Brittberg 1999).
There are a host of problems with these surgical interventions. For example,
mosaicplasty produces significant morbidity at the donor site, and techniques employing
subchondral penetration have been shown to produce functionally inferior repair tissue
(fibrocartilage) instead of true hyaline cartilage, especially at longer post-operative times
(Breinan, Minas et al. 2001).
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1.3 Cartilage Repair: Tissue Engineering Approaches
Cartilage treatments exist along a continuum with classical and usually highly
invasive surgical interventions such as TJA on one end and less invasive tissue
engineering interventions on the other, but many of the treatments currently in use or
under investigation possess attributes from both ends of the spectrum. Tissue engineering
typically involves three primary components: cells, three-dimensional scaffolds which
mimic the cells' extracellular matrix and regulators that affect cellular processes. Many
diverse examples from each of these categories are currently under investigation.
Tissue engineering approaches circumvent the previously mentioned problem by
introducing a temporary matrix that will provide the cells in the cartilage (or those added
during the treatment) with the substrate that they require to begin their metabolic
activities. In this respect, the surgical techniques employing subchondral penetration and
fibrin clotting may be considered to possess some of the attributes of a tissue engineering
approach. Usually TE substrates are designed to biodegrade as a part of the remodeling
process, to be replaced eventually by newly synthesized ECM. The kinetics of this
process are important yet little understood (Gordon TD 2004).
1.3.1 Cells
While chondrocytes are an obvious choice of cells to be used in a cartilage TE
system, many studies have been performed with cells from synovium, perichondrium
(Dounchis, Goomer et al. 1997), periosteum (O'Driscoll 1999), and bone marrow derived
stem cells.
1.3.2 Scaffold Materials
There are a wide range of materials currently employed as matrices - collagen
(Grande, Halberstadt et al. 1997; Nehrer, Breinan et al. 1997), fibrin (Ameer, Mahmood
et al. 2002; Hunter, Mouw et al. 2004), polylactic (Chu, Coutts et al. 1995; Dounchis,
Goomer et al. 1997; Saldanha and Grande 2000; Chen, Sato et al. 2003) and polyglycolic
acid (Freed, Vunjak-Novakovic et al. 1994; Vunjak-Novakovic, Obradovic et al. 1998;
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Chen, Sato et al. 2003), agarose, self assembling peptide hydrogels (Kisiday, Jin et al.
2002) and alginate - to name a few. And much attention has been given to the proper
modification (Lee, Grodzinsky et al. 2001) of these materials to ensure their
biocompatibility and ability to induce and/or maintain chondrocytic phenotype when
seeded with cells.
1.3.3 Regulators
The literature on the effects of chemical regulators is vast and includes discussion
of growth factors such as insulin-like growth factor (IGF), fibroblast growth factor
(FGF), etc.; factors promoting differentiation of chondroprogenitor cells such as
dexamethasone and transforming growth factor (TGF); and serum (Hascall, Handley et
al. 1983; McQuillan, Handley et al. 1986; McQuillan, Handley et al. 1986). While the
biochemical pathways of mechanotransduction are still incompletely understood, there is
a similarly large literature concerning the effects of mechanical regulators on cells (Gray,
Pizzanelli et al. 1989; Sah, Kim et al. 1989; Larsson, Aspden et al. 1991; Sah, Doong et
al. 1991; Greco, Specchia et al. 1992; Guilak, Meyer et al. 1994; Kim, Sah et al. 1994;
Lee and Bader 1997; Lee, Noguchi et al. 1998; Grodzinsky, Levenston et al. 2000; Lee,
Noguchi et al. 2000; Mauck, Soltz et al. 2000; Bonassar, Grodzinsky et al. 2001; Kisiday,
Jin et al. 2002; Lee, Grodzinsky et al. 2003).
1.4 Tissue Engineering Subchondral Bone
Cartilage defects often may be connected - causally and/or temporally - with
defects in bone (Gao, Dennis et al. 2002; Schaefer, Martin et al. 2002; Sherwood, Riley et
al. 2002; Cao, Ho et al. 2003). Consequently, there is increasing interest in osteochondral
tissue engineering in which specific factors from the three TE components (cell, scaffold,
and regulator) conducive to the development of bone are employed to produce constructs
that can repair simultaneous defects in cartilage and the underlying bone. The molecular
level explanation for the stiffness of bone differs from that of cartilage, but in the final
analysis any successful scaffold must possess sufficient mechanical integrity to sustain
the loads it will experience in vivo. Critical properties of such scaffolds include stiffness
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or modulus and ultimate strength. In addition to the investigation of the biochemical and
mechanical factors affecting chondrocytes, a study was performed to determine critical
mechanical properties of a novel bone scaffold material and to compare them to native
bone. In the case of bone, it is particularly important to employ a scaffold that is
comparable in stiffness to bone. If the construct's stiffness is significantly greater than
the surrounding bone, stress shielding and concomitant bone density loss may occur;
thus, it is important to design an implant that will either degrade relatively rapidly or that
will be of comparable stiffness to native bone.
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1.5 Specific Aims
This thesis investigates the effects of two different classes of regulators of
chondrocyte behavior: chemical growth factors and mechanical loading. The overall aim
of the work is to determine to what extent these regulators influence the maturation of
chondrocyte-seeded constructs. In addition to the cartilage related work, a study of the
compressive mechanical properties of several different bone scaffold materials was
performed in anticipation of the clinical demand for composite bone-cartilage scaffolds.
This thesis attempts to answer the following questions:
1. FGF Treatment (chapter 2)
a. Does the addition of 5 ng/ml fibroblast growth factor (FGF-2) to canine articular
chondrocyte-seeded type II collagen-GAG scaffolds cause these scaffolds to
attain higher moduli after 28 days of culture than untreated controls?
2. EDAC Cross-linking Treatment (chapter 2)
a. What is the relationship between the duration of EDAC cross-linking treatment
and the modulus of unseeded type II collagen-GAG scaffolds?
b. What is the optimum cross-linking time?
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3. Dynamic Compression (chapter 3)
a. In serum-free medium, does the application of 3% dynamic compressive strain to
canine articular chondrocyte-seeded type II collagen-GAG scaffolds increase the
rates of protein and proteoglycan biosynthesis?
b. Are the results in serum-free medium comparable to those performed in serum-
supplemented medium (comparison with (Lee, Grodzinsky et al. 2003))?
c. Does such compression increase the absolute amount of GAG and protein
deposited in the scaffolds?
d. Does such compression increase the modulus of the scaffolds?
4. Orthoss Mechanical Properties (chapter 4)
a. Do the ultimate compressive strength and modulus vary with chemical
composition for Orthoss bone scaffold?
b. Which formulation produces the greatest strength and stiffness?
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2. THE EFFECTS OF FGF-2 AND CROSS-LINKING TIME
ON THE COMPRESSIVE MODULUS OF ADULT CANINE
CHONDROCYTE-SEEDED TYPE 11 COLLAGEN-GAG
SCAFFOLDS GROWN IN SERUM-FREE MEDIUM
2.1 Introduction
In one approach to articular cartilage tissue engineering an immature cartilaginous
construct, developed from a chondrocyte-seeded scaffold, is implanted into a defect,
where it will then mature and remodel in vivo. While these maturation processes are
complex, primary features include the synthesis of extracellular matrix (ECM)
components such as proteoglycans (PG) and type II collagen by the chondrocytes and the
proliferation of the cells themselves. The synthesized ECM is deposited into the scaffold,
gradually replacing the biodegrading original scaffold. The result of this process is a
stiffer, more tissue-like material than the original scaffold.
The mechanical properties of a construct at the time of implantation are likely to
significantly affect the clinical outcome: a stiff scaffold well-populated with ECM is
much more likely to sustain the biomechanical forces it will experience in vivo than a
compliant scaffold containing less PG and collagen. Furthermore, an implant's rapid
integration with the healthy surrounding cartilage tissue depends on its ability to actively
synthesize ECM.
One way to assess the rate of ECM deposition is to measure the mechanical
stiffness of the scaffold. Hence, the objective of this study is to evaluate the compressive
modulus of canine articular chondrocyte-seeded type II collagen-GAG scaffolds after 28
days of culture with and without fibroblast growth factor (FGF-2) in order to determine
whether this regulator can facilitate scaffold maturation. Elevated modulus values after
treatment with FGF would be interpreted as a positive finding.
Prior investigations have demonstrated that the addition of FGF-2 during
monolayer in vitro expansion stimulates chondrocytes' proliferation and later, their GAG
production in 3-dimensional culture (scaffolds) (Martin, Vunjak-Novakovic et al. 1999;
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Martin, Suetterlin et al. 2001). Other researchers have also found that FGF-2 in
monolayer culture increases chondrocyte differentiation while increasing proliferation. It
should be noted that some researchers have found that when FGF was used in 3-
dimensional culture a downregulation of GAG, type II collagen, wet weight and stiffness
were observed (Jakob, Demarteau et al. 2001; Pei, Seidel et al. 2002).
Type II collagen scaffolds have yielded promising results for articular cartilage
tissue engineering. In a recent canine study type II collagen-GAG scaffolds facilitated
the increased production of viable repair tissue in cartilage defects, as demonstrated by
comparison of their histomorphometric results with those from autologous chondrocyte
implantation. These constructs (cultured without FGF-2) yielded better
histomorphometric results than autologous chondrocyte implantation (Lee, Grodzinsky et
al. 2003).
In addition to increasing scaffold stiffness via chemical regulator-mediated
increases in ECM deposition, the intrinsic stiffness of a scaffold material is an important
consideration when choosing a biomaterial for tissue engineering. A stiffer (unseeded)
starting material will likely produce a stiffer, more physiologically appropriate implant
than a more compliant scaffold. Prior studies of the effects of various cross-linking
treatments on collagen scaffolds concluded that dehydrothermal treatment (DHT)
followed by immersion in 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
hydrochloride (EDAC) and N-hydroxysuccinimide (NHS) produced scaffolds with the
greatest degree of cross-linking, and hence the lowest contraction and highest modulus
(Weadock, Olson et al. 1983; Weadock, Miller et al. 1995; Olde Damink, Dijkstra et al.
1996; Weadock, Miller et al. 1996; Lee, Grodzinsky et al. 2001).
In order to optimize the EDAC cross-linking process a study of the kinetics of the
reaction was performed. It was hypothesized that greater cross-linking times would
significantly increase the stiffness of unseeded scaffolds, and that a more mechanically
robust tissue-engineered construct could be produced by treating these maximally cross-
linked cell-seeded scaffolds with FGF-2. The ultimate goal of these studies is to shorten
the pre-implantation culture period and increase the robustness of such constructs in
clinical applications.
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2.2 Methods
2.2.1 Scaffold Fabrication and Cross-Linking
Sheets of the scaffold, 3-mm thick, were produced by freeze-drying a porcine type
II collagen-GAG slurry (Geistlich Biomaterials, Wolhusen, Switzerland) as previously
reported for type I collagen-glycosaminoglycan matrices (Yannas, Lee et al. 1989).
Eight-mm diameter samples punched from sheets of the material were cross-linked by
dehydrothermal treatment followed by immersion in an aqueous solution of 14 mM 1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride and 5.5 mM N-
hydroxysuccinimide (EDAC) (Olde Damink, Dijkstra et al. 1996). After cross-linking
the scaffolds were transferred to 50 ml centrifuge tubes and were rinsed four times with
sterile distilled water. During each rinse stage, the centrifuge tubes were nutated for
approximately 30 minutes before siphoning off the water. After the final rinse, the
scaffolds were stored in fresh, sterile water.
Comparable type II collagen scaffolds were previously (Nehrer, Breinan et al.
1997) found to have an average pore size of 86 ptm and 93% porosity. A prior study
employing SDS-polyacrylamide gel electrophoresis (Nehrer 1998) confirmed that the
scaffolds contained primarily type II collagen. In the prior study there were no
significant differences in these properties anticipated among the specimens.
2.2.2 Cell Isolation and Culture
Articular cartilage was harvested from the knee (stifle) joints of five adult
mongrel dogs. Chondrocytes were isolated from the cartilage by digesting the tissue first
with pronase (20 U/ml, lhr) and subsequently with collagenase (200 U/ml), overnight, as
previously described (Kuettner, Pauli et al. 1982). After isolation, the cells were washed
several times in a serum-free base (SFB) culture medium, adapted from a formulation
from Jakob (Jakob, Demarteau et al. 2001) (see Appendix) supplemented with 10% fetal
bovine serum (FBS, Gibco Life Technologies, Carlsbad, CA). The cells were suspended
in medium and 10% dimethyl sulfoxide (DMSO) at a concentration of 106 cells/ml and
stored at -80*C.
After cells from all five animals had been collected they were thawed by adding
drops of SFB medium supplemented with 10% FBS, and the cells were washed several
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times using fresh medium. The cells were counted using a hemacytometer; typically 50%
of the initial number of cells was viable upon thawing.
Keeping each animal separate, the cells were suspended in a growth factor and
FBS supplemented expansion medium (see Appendix) and then plated in 75-cm 2 flasks
(15 ml of cell suspension/flask) at a concentration of approximately 2 million cells/flask.
The cells were incubated at 37 0 C and 5% CO 2. Once the chondrocytes reached
confluence, which was after 8-9 days for the first subculture, they were trypsinized,
resuspended and replated into 75-cm2 flasks at the same concentration. The cells reached
confluence (passage 1) after 4-5 days.
2.2.3 Cell Seeding and Culture of Collagen Matrices
After the first passage the chondrocytes were transferred to serum-free medium
containing ITS and then dynamically seeded (1.5 hours on a nutator) into scaffolds
(2x 106 cells/scaffold) that had been EDAC cross-linked for 10 min. It has been estimated
based on our prior studies that this dynamic seeding method results in approximately
50% of the chondrocytes being attached to the scaffolds, yielding a cell density
approximately equal to that in articular cartilage (10,000 cells/mm 3) (Venn and Maroudas
1977). After seeding, the matrices were incubated in 1.5 ml of medium per agarose-
coated well in 24-well plates. Medium was exchanged every two to three days.
Half of the scaffolds received FGF-2 (5 ng/ml) with each medium change.
Scaffolds were incubated for 28 days and subsequently terminated by placing them in
PBS.
2.2.4 Mechanical Testing of Scaffolds
Within 48 hours of sacrifice, the thicknesses of the scaffolds were measured with
a custom fabricated micrometer with an LED indicating the jaw-to-jaw distance when an
electrical circuit was first formed by the micrometer's two platens' contact with the
scaffold. Scaffolds were then placed in a PBS-filled polymethylmethacrylate (PMMA)
chamber mounted in the lower jaw of a Dynastat Mechanical Spectrometer (IMASS,
Hingham, MA). A 50-gram load cell (Sensotec, Cleveland, OH) fitted with a 9.5-mm
diameter PMMA cylindrical plunger was fixed in the upper jaw of the Dynastat and the
19
distance between the plunger and the lower chamber set to the thickness of the hydrated
scaffold.
The scaffolds were then immediately subjected to uniaxial compression and their
unconfined stress-strain responses were measured. The Dynastat was then programmed
to compress the specimen at a rate of approximately 2.5 pm/sec while force and
displacement data were recorded at a sampling rate of 0.1 / second. The compression
was terminated at 60% engineering strain (AL/Lo). The recorded force/displacement data
were converted to engineering stress/strain and plotted in EXCEL. The equilibrium
modulus was defined as the slope of the stress-strain data over the 20-50% strain range.
The moduli of unseeded scaffolds after six different durations (n=2-3 for each
time) of EDAC treatment (0, 1, 5, 10, 60, and 120 minutes) were measured.
2.2.5 Statistical Analysis
Data from all assays are reported as the mean ± standard deviation. Analysis of
variance (ANOVA) and Fisher's protected least squares differences (PLSD) post-hoc
testing were performed using StatView (SAS Institute Inc, Cary, NC). The criterion for
statistical significance was set at p = 0.05.
2.3 Results
2.3.1 Effect of EDAC Cross-linking Time On Modulus of Unseeded Scaffolds
The data (Fig. 1) indicate that scaffold modulus is related exponentially to EDAC
treatment time. For the EDAC protocol used in this study, modulus M(t) vs. EDAC time
was described (r2 = 0.74) by a kinetics equation of the form
M(t) = M + a*(I-e -t),
where the time constant, -c = 6.07 min., a = 3.43 kPa, and the non-EDAC cross-linked
stiffness, M, = 0.83 kPa. The average value for the equilibrium modulus of the unseeded
scaffolds EDAC cross-linked for 10 min (n=5) was 3.1 kPa with a 95% confidence
interval of 2.7-3.5 kPa (data not shown).
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Figure 1. Effects of EDAC
collagen-GAG scaffolds.
40 60
Time (min) 80 100
120
cross-linking time on the unconfmed compressive modulus of unseeded type II
2.3.2 Effect of FGF-2 on Modulus of Seeded Scaffolds
The correlation coefficients for the individual linear regressions over the 20-50%
strain range were between 0.98 and 1.0; however, there was considerable variation in the
modulus of constructs prepared with cells from the different animals. The mean value for
the modulus of the cell-seeded constructs cultured in medium without FGF-2
supplementation for 28 days was almost 2-fold higher than the non-seeded controls
(EDAC cross-linked for 10 min). However, the high level of inter-animal variation
prevented this result from achieving statistical significance (unpaired Student's t test;
p=0.09).
Treatment of the constructs with FGF-2 resulted in a statistically significant
(paired Student's t test; p=0.02 ) doubling of the modulus, compared to the non-treated
cell-seeded constructs: 17.4 ± 9.0 versus 8.8 ± 5.5 kPa (Fig. 3). A typical stress-strain
curve for FGF-treated and control scaffolds from animal B is shown in Fig. 2. The
21
6
5
4
3
2
1
0
-V
a.)
-1
)
terval):
linear-fit equations are displayed in the figure and the high degree of linearity over this
strain range is evident from the high values for the goodness of fit parameter.
During weeks 2 to 4 of culture the coloration of the medium of the non-FGF-
treated and FGF-treated groups differed dramatically, reflecting the effects of the growth
factor on the metabolism of the cells.
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Figure 2. Stress-strain response of cell-seeded (from animal B) collagen-GAG scaffolds, indicating the
higher modulus of FGF treated scaffold (upper curve) when compared to scaffolds receiving no FGF (lower
2 curves).
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Figure 3. Equilibrium unconfined compressive moduli for constructs prepared using chondrocytes from 5
animals (A-E).
2.4 Discussion
FGF-2 treatment over a 4-week culture period resulted in constructs that were
markedly stiffer than untreated scaffolds. The high degree of inter-animal variation was
not anticipated, but may be a result of differences in age, incipient osteoarthritis or other
degenerative joint conditions, degree of exercise provided to different animals, or other
factors.
Since biochemical assays were not performed with these scaffolds, it was not
possible to determine the origin of the modulus increase. It is believed that the increased
stiffness was due to upregulated ECM production and deposition by the cells. However,
it is also possible that the per cell rate of ECM production was not changed but the
proliferation of cells was increased, leading to a net increase in ECM deposition. Either
of these situations could lead to the observed variation in medium coloration; elevated
levels of metabolic byproducts discharged to the medium could be caused by either more
cells working at average rates or by fewer cells working at greater rates. Future work
will be required to distinguish between these or other possible explanations of the effects
of FGF on the stiffness.
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The kinetics data for the EDAC cross-linking indicate that 20 minutes of
treatment (i.e., approximately 3) increased the intrinsic modulus to approximately 95%
of the maximum obtainable by this method. Thus, we may have realized slightly stiffer
seeded matrices if we had started with matrices that had received 20 minutes of cross-
linking rather than 10 minutes. The difference in stiffness would likely have been small.
During EDAC cross-linking the scaffolds tend to trap air bubbles internally,
preventing the solution from fully penetrating the scaffold. A pilot-study revealed the
following solution to this problem. Place the scaffolds in a solution (either the EDAC
cross-linking solution, sterile water, ethanol, etc.) under light vacuum in a vacuum flask.
Then very rapidly allow the pressure to rise (by quickly removing the vacuum tube from
the flask in a sterile biosafety cabinet). This shock dislodges the bubbles from the
scaffolds very effectively.
Future in vivo work will be required to determine if FGF-2 treatment can reduce
the culture period required before implantation of the constructs and the relationship
between the compressive modulus of the construct and treatment outcome.
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3. DYNAMIC MECHANICAL STIMULATION OF
ARTICULAR CHONDROCYTES IN COLLAGEN-GAG
MATRICES AND SERUM-FREE MEDIUM
3.1 Introduction
In addition to biochemical stimulation, it is well-known that mechanical loading is
an important regulator of the metabolic processes of chondrocytes in situ. During normal
physical activities articulating joints are subjected to a wide range of stresses, and sensing
the induced strains, the chondrocytes modify their biosynthetic behavior. Static strains
reduce the cellular production of proteins and proteoglycans that constitute the ECM.
Dynamic strains, however, increase the production of ECM molecules in an amplitude
and frequency dependent manner. Thus, it appears that the effects of "exercise" can be
traced to cellular and molecular levels. Chondrocytes receiving such mechanical loading
produce augmented levels of ECM molecules relative to static conditions, thus
strengthening their ability to withstand the strains they experience.
Recent investigations have also shown that dynamic loading can increase
chondrocytes' ECM biosynthesis in cell-scaffold systems in vitro (Gray, Pizzanelli et al.
1988; Gray, Pizzanelli et al. 1989; Sah, Kim et al. 1989; Larsson, Aspden et al. 1991;
Greco, Specchia et al. 1992; Guilak, Meyer et al. 1994; Kim, Sah et al. 1994; Lee and
Bader 1997; Bonassar, Grodzinsky et al. 2000; Grodzinsky, Levenston et al. 2000; Lee,
Noguchi et al. 2000; Mauck, Soltz et al. 2000; Wilkins, Browning et al. 2000; Bonassar,
Grodzinsky et al. 2001; Gooch, Blunk et al. 2001; Mauck, Seyhan et al. 2002; Lee,
Grodzinsky et al. 2003; Mauck, Nicoll et al. 2003; Hunter, Mouw et al. 2004). Since the
ECM is responsible for the high compressive modulus of cartilage in vivo, we
hypothesized that increased ECM production within these scaffolds due to dynamic
loading would be reflected in increased scaffold stiffness. In this study, chondrocyte-
seeded scaffolds were subjected to dynamic compression and the effects of this treatment
on the proliferation of the chondrocytes, their synthesis of ECM, and the stiffness of the
scaffolds were measured.
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3.2 Materials and Methods
3.2.1 Scaffold Fabrication and Cross-linking
Sheets of the scaffold, 3-mm thick, were produced by freeze-drying a porcine type
II collagen-GAG slurry (Geistlich Biomaterials, Wolhusen, Switzerland) as previously
reported for type I collagen-glycosaminoglycan matrices (Yannas, Lee et al. 1989).
Eight-mm diameter samples punched from sheets of the scaffold were cross-linked by
dehydrothermal treatment followed by immersion in a solution of 14 mM 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride and 5.5 mM N-hydroxysuccinimide
(EDAC) (Olde Damink, Dijkstra et al. 1996). Comparable type II collagen scaffolds
were previously (Nehrer, Breinan et al. 1997) found to have an average pore size of 86
pm and 93% porosity. A prior study employing SDS-polyacrylamide gel electrophoresis
(Nehrer 1998) confirmed that the scaffolds contained primarily type II collagen. In the
prior study there were no significant differences in these properties anticipated among the
specimens.
3.2.2 Cell Isolation, Culture and Seeding
Articular cartilage was harvested from the stifle joints of six adult dogs.
Chondrocytes were isolated from the cartilage by digesting the tissue first with pronase
(20 U/ml, lhr) and subsequently with collagenase (200 U/ml), overnight, as previously
described (Kuettner, Pauli et al. 1982). After isolation, the cells were washed several
times in a serum-free base (SFB) culture medium, adapted from a formulation from Jakob
(Jakob, Demarteau et al. 2001) (see Appendix) supplemented with 10% fetal bovine
serum (FBS, Gibco Life Technologies, Carlsbad, CA). The cells were suspended in and
10% dimethyl sulfoxide (DMSO,) at a concentration of 106 cells/ml and stored in liquid
nitrogen.
After cells from all six animals had been collected they were thawed by adding
drops of SFB medium supplemented with 10% FBS, and the cells were washed several
times using fresh medium. The cells were counted using a hemacytometer; typically 50%
of the initial number of cells was viable upon thawing.
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Keeping each animal separate, the cells were suspended in a growth factor and
FBS supplemented expansion medium (see Appendix) and then plated in 75-cm2 flasks
(15 ml of cell suspension/flask) at a concentration of approximately 2 million cells/flask.
The cells were incubated at 37*C and 5% CO 2. Once the chondrocytes reached
confluence, which was after 8-9 days for the first subculture, they were trypsinized,
resuspended and replated into 75-cm 2 flasks at the same concentration. The cells reached
confluence (passage 1) after 4-5 days.
After the first passage the chondrocytes were transferred to serum-free medium
containing ITS and then dynamically seeded into scaffolds (2x 106 cells/scaffold) that had
been EDAC cross-linked for 10 min. Medium (1.5 ml medium/scaffold) was changed
every 2-3 days. Scaffolds were incubated for 19 days and subsequently terminated by
placing them in PBS.
3.2.3 Dynamic Mechanical Compression
The thicknesses of the scaffolds were measured with a custom fabricated
micrometer with an LED indicating the jaw-to-jaw distance when an electrical circuit was
first formed by the micrometer's two platens' contact with the scaffold. Scaffolds were
placed in polysulfone chambers with 0.6 ml of radiolabeled serum-free medium and
transferred to an incubator-housed mechanical spectrometer. The platens of the loading
chamber were individually adjusted so that they would just touch the surface of each
scaffold. Scaffolds were subjected to 24 or 96 hours of 0.1 Hz, 3% sinusoidal
compressive strain superimposed on a 10% offset strain (10%/60 sec) (Frank, Jin et al.
2000; Lee, Grodzinsky et al. 2003).
Since all the scaffolds were compressed by the spectrometer the same absolute
distance, only scaffolds of exactly the same thickness would experience identical strains.
Although the tested scaffolds were not identical in thickness, individual scaffolds did not
typically differ by more than 10% from the average thickness. Thus, the dynamic and
offset strains were based on the average thickness of all the scaffolds in the polysulfone
loading chambers.
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3.2.4 DNA Analysis
The DNA content of the matrices was measured using the Hoechst 33258 dye
method (Kim, Sah et al. 1988). A 20 [tl aliquot of the proteinase K digest mixed with
180 d of Hoechst dye solution (10% Hoechst dye in 10 mM Tris, 1mM Na2EDTA and
0.1 M NaCl, pH 7.4) was assayed fluorometrically. The results were extrapolated from a
standard curve established using calf thymus DNA. The DNA contents of unseeded
matrices were measured as controls, and subtracted from values obtained for the cell-
seeded samples.
3.2.5 GAG Analysis
The GAG content of the matrices was determined by the dimethylmethylene blue
(DMMB) dye assay (Famdale, Sayers et al. 1982). A 100 pl aliquot of the proteinase K
digest was mixed with 3 ml of the DMMB dye and the absorbance at 535 nm was
measured with a spectrophotometer (Ultrospec 4050, LKB Biochrom, Cambridge,
England). The GAG content of the matrices was derived from comparisons with a
standard curve produced from measurements of shark chondroitin-6-sulfate standards.
3.2.6 Proline and Sulfate Radiolabel Incorporation to Evaluate Protein and
Glycosaminoglycan Synthesis Rates
After 18-19 days of culture in serum-free medium the cell-seeded matrices were
transferred to the polysulfone loading chamber and incubated in medium containing 10
p.Ci/ml of 3H-proline and 20 ptCi/ml of 3S-sulfate during the loading to determine protein
(assumed to be primarily type II collagen) and GAG synthesis rates, respectively. At the
end of the 24 or 96 hour radiolabeling period, the matrices were washed (5 x 15 min at
4C) in phosphate buffered saline (PBS) supplemented with unlabeled proline (1.0 mM)
and sulfate (0.8 mM).
Scaffolds were lyophilized overnight and then solubilized for at least 24 hours at
60'C with 1 ml of proteinase K solution (100 tg in 1 ml 50 mM Tris-HCl buffer with 1
mM CaCl 2). In order to determine the radioactivity content, 200 p1 aliquots of the digest
were mixed with 2 ml scintillation fluid (CytoScint ES, ICN Biomedicals Inc., Irvine,
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CA) and counted in a liquid scintillation counter (Rack-Beta 1211, LKB, Turku, Finland).
The 3H and 3 5S counts per minute were recorded (channel A recorded activity from 0.5 -
18.6 keV and channel B recorded activity from 18.6 - 156 keV) with corrections for
spillover and then converted to nanomoles of incorporated radiolabel. The counting
period for each sample was 3 minutes. Quenching effects were assumed to be constant
throughout all measurements and were, therefore, not directly treated. Counts were
normalized both to DNA content and radiolabeling period.
3.2.7 Mechanical Testing
A random selection of scaffolds was allotted for mechanical testing after the
dynamic compression. These scaffolds were not lyophilized or treated with Proteinase-
K. Their moduli were determined by 5% sequential ramp (30 seconds) and hold (90
seconds) displacements from 0-55% strain. The sampling time was 0.1 seconds for force
and displacement measurements. The data were processed by averaging the last 10 force
and displacement data points for each of the 11 ramp sequences. After multiplying by the
appropriate factors, the data were transformed into 11 points on a stress vs. strain graph
and a line was fitted to these data. The slope of the initial linear region was taken as the
modulus.
3.2.8 Statistical Analysis
Data from all assays are reported as the mean ± standard error of the mean (
SEM). Analysis of variance (ANOVA) and Fisher's protected least squares differences
(PLSD) post-hoc testing were performed using StatView (SAS Institute Inc, Cary, NC).
The criterion for statistical significance was set at p = 0.05.
3.3 Results
3.3.1 Radiolabel Incorporation
The power of the ANOVAs comparing the effects of 24 hours of loading on synthesis
of proline and sulfate in the scaffolds and the medium were all very low (between 0.05
and 0.297), indicating that these assays were inconclusive. The low power values signify
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that the experiment was unable to detect a difference between the dynamically loaded and
the free-swelling specimens even if one did in fact exist (type II error). This was due to
different factors, but in all cases the differences between the means (experimental vs.
control treatments) were small. In some comparisons the variance was also quite large
and the sample size small. The net effect is that while trends may be noted, statistically
significant conclusions are impossible with the current data set.
The averages of the total newly synthesized proline (± SEM) in the media with
and without 24 hours of dynamic loading were 26.897 (2.188) and 26.301 (4.532) nmol,
respectively (p = 0.7017, power = 0.065). Average proline levels in the scaffolds were
0.01485 (0.00528) and 0.01474 (0.00207) nmol, respectively (p = 0.9592, power = 0.05).
No proline synthesis data were recorded for the specimens dynamically compressed for
96 hours.
The amounts of sulfate in the loaded specimens and media were elevated, but as
with total proline synthesis, these results were not significant. The averages of the total
newly synthesized sulfate (± SEM) in the media with and without 24 hours of dynamic
loading were 227.179 (11.98) and 214.392 (24.194) nmol, respectively (p = 0.139, power
= 0.297). Average sulfate levels in the scaffolds were 0.058 (0.029) and 0.053 (0.013),
respectively (p = 0.6547, power = 0.071). No sulfate synthesis data were recorded for the
specimens dynamically compressed for 96 hours.
The rates of biosynthesis (normalized by the radiolabeling period and the mass of
DNA) were calculated for the scaffolds with and without loading. Proline synthesis rates
were 0.00146 (0.00178) and 0.00109 (0.00144) nmol, respectively (p = 0.6437, power =
0.072). Sulfate synthesis rates were 0.00594 (0.00793) and 0.00360 (0.00452) nmol,
respectively (p = 0.4875, power = 0.100).
3.3.2 GAG Content
The net GAG contained in the matrices was measured, but again, the data were
inconclusive, as indicated by low power values. The averages (Fig. 4) of the total GAG
(± SEM) in the scaffold with and without 24 hours of loading were 0.387 (0.153) and
0.844 (0.530) tg, respectively (p = 0.3032, power = 0.164). The averages (Fig. 5) of the
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total GAG (± SEM) in the scaffold with and without 96 hours of loading were 0.185
(0.340) and 0.347 (0.101) pig, respectively (p = 0.6855, power = 0.066).
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Figure 4. Average (± SEM) net GAG content for seeded matrices dynamically compressed for 24 h is
lower than for uncompressed matrices.
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Figure 5. Average (± SEM) net GAG content for seeded matrices dynamically compressed for 96 h is
lower than for uncompressed matrices.
3.3.3 DNA Content
The net DNA contained in the matrices was measured, but the data were
inconclusive, as indicated by low power values. The averages (Fig. 6) of the total DNA
(± SEM) in the scaffold with and without 24 hours of loading were 1.107 (0.270) and
1.423 (0.372) pg, respectively (p = 0.498, power = 0.099). The averages (Fig. 7) of the
total DNA (± SEM) in the scaffold with and without 96 hours of loading were 0.227
(0.052) and 0.264 (0.028) jLg, respectively (p = 0.573, power = 0.081).
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Figure 6. Average (± SEM) net DNA content for seeded matrices dynamically compressed for 24 h is
lower than for uncompressed matrices.
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Figure 7. Average ( SEM) net DNA content for seeded matrices dynamically compressed for 96 h is
lower than for uncompressed matrices.
3.3.4 Modulus Measurements
The moduli of dynamically compressed (96 hours) cell seeded matrices were
compared to free-swelling specimens and to unseeded matrices. The average (± SEM)
moduli for unseeded matrices, seeded without dynamic compression, and seeded with
dynamic compression were 2.147 (0.310), 2.245 (0.105), 2.823 (0.130), respectively.
These data (Fig. 8) were inconclusive (p = 0.0522, power = 0.322).
In light of the low statistical power of these comparisons, any conclusions
regarding the modulus data are likely to be spurious. Nonetheless, the post-hoc analysis
was performed for completeness. The results suggest that the dynamically compressed
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scaffolds may have a greater modulus than the unseeded scaffolds (p = 0.0776). The
other comparisons were not meaningful.
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Figure 8. Comparison of moduli from unseeded scaffolds, free-swelling
dynamically compressed (96 h) cell-seeded scaffolds (n=3, n=2, n=3).
cell-seeded scaffolds, and
3.4 Discussion
The matrices used in this study were fabricated in a previously untested set of
polysulfone molds. Preliminary pore-size analysis performed after the experiments
described in this chapter suggests that the diameter of the pores of the matrices used in
these experiments was much larger (300-400 ptm) than the original estimate (90 ptm).
Although it was not anticipated at the outset of the experiment, it is now believed that
differences in the geometry and material of the molds used to make the matrices for these
experiments had a profound effect on the freeze-drying process. Further work will be
required to determine the most important factors, but these may include a retardation of
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the heat transfer rate due to increased mold wall-thickness relative to the molds used for
scaffold production in the experiments in chapter 2 of this thesis.
Although the origin of the drastic increase in pore diameter is unclear, the effect
on cell culture was abundantly clear. The very low levels of biosynthesis, GAG, and
DNA present at the conclusion of the culture period confirm the results of other
researchers who have found that outside a narrow range of pore diameters the
effectiveness of scaffolds decreases dramatically (Yannas 2001). During cell culture
there was no change observed in the medium coloration - another indicator of low
metabolic activity. Thus, the efforts of these experiments are believed to have been
thwarted by a scaffold microstructure that was incapable of supporting and promoting a
large and active chondrocyte population. While it is difficult to make further conclusions
based on experiments with a biologically inactive matrix, the GAG and DNA levels
within the scaffolds appeared to decrease substantially from 24 to 96 hours of dynamic
compression. This observation is supported by numerous other studies which found that
in compressing the scaffolds, the DNA and GAG were expelled to the medium. For
longer compression periods a corresponding greater amount of DNA and GAG should be
expelled to the medium.
Radiolabel analysis indicated that the vast majority of newly synthesized protein
and GAG was found in the medium and the levels retained in the matrices were
essentially zero.
In addition to the unwitting use of biologically inactive matrices, another reason
for the inconclusive results is that the procedure for dynamic loading was not optimized.
The extreme compliance of the matrices made it difficult to accurately determine their
thickness without compressing them. Variations in the thickness resulted in different
applied strains during the dynamic loading. In some of the early data the individual
polysulfone platens would stick, and it is not clear that they were in contact with the
matrices during the entire loading cycle. This was later corrected, but the experiment
should be repeated in order to produce a consistent data set.
The modulus data were inconclusive for several reasons. First, several of the
samples were infected by the time they were removed. This was due to the fact that the
polysulfone chamber was not designed to maintain sterility. Previous use of this fixture
36
never exceeded 24 hour compression periods, so sterility was not an issue. Second, a
significant amount of the medium in the polysulfone chambers evaporated during the 96
hour compression period. Again, this was not anticipated since the fixture had never
been used for such an extended period.
In addition to the EDAC treated scaffolds, earlier experiments were initiated using
DHT treated matrices. It was not possible to collect data from these specimens because
during culture the matrices' mechanical properties degraded drastically. Some matrices
dissolved in the media and others assumed the consistency of a highly viscous liquid
rather than a solid capable of sustaining compression. This result was observed in
independent experiments by other researchers in the same lab, but the reason is unclear.
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4. MECHANICAL PROPERTIES OF ORTHOSS BONE
SCAFFOLD IN UNIAXIAL COMPRESSION
4.1 Introduction
Many different materials and processes for the production of osteo- and
osteochondral implants are found in the literature. These include nanofibers, poly-D,L -
lactide (PDLLA), poly(lactide-co-glycolide) (PLGA), bioglass@, poly(3-
hydroxybutyrate) (PHB), poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx),
poly(x-hydroxyesters), collagen and chitin. Most engineered bone scaffold systems
contain at least some hydroxyapatite (HAP) - the primary constituent of normal bone and
teeth.
Chemical composition, porosity and mechanical properties are interdependent
parameters. Thus, changing the porosity of the scaffold, for example, will affect its
mechanical properties. It has often been suggested in the literature that a suitable
scaffold should be biomimetic; that its properties should closely approximate those found
in vivo. In the case of bone tissue, it has been shown that the introduction to a defect site
of materials which are either much stiffer than native bone or much more compliant will
produce negative results. In the former case, stress shielding and subsequent bone
resorption will occur in the surrounding tissue; while in the latter case, fibrous tissue will
form instead of bone.
In one HAP scaffold study researchers found that the compressive strength and
compressive modulus of their 40% porous scaffolds were 30+/-8 MPa and 1.4+/-0.4 GPa
(Chu, Orton et al. 2002). However, the scaffolds tested in those experiments had a highly
ordered and closed-cell microstructure, making it difficult to directly compare or even to
scale between that material and scaffolds such as Orthoss with a more random and open-
cell architecture.
For scaffolds similar in microstructure to Orthoss, the elastic modulus and
modulus of rupture (related to the ultimate compressive strength) should scale with the
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ratio of their densities. (Relative density is equal to 1 - % porosity.) Elastic moduli and
moduli of rupture are related as
E* =E J
* )3/2
-* =0.2cr-
where the subscript denotes the properties of the solid (non-porous) material and the
superscript asterisk denotes the porous properties.
From these relations it should be possible to compare the mechanical properties of
Orthoss found in the current work with the properties of other scaffolds as reported in the
literature. Lin et al. used a poly (L-lactide-co-DL-lactide) scaffold to obtain structures
with 99% interconnectivity of the scaffold porosity and six different porosity levels
(between 58.3% and 80.3%). The scaffold with maximum porosity had an average
compressive modulus and ultimate strength of 43.5 MPa and 2.7 MPa, respectively (Lin,
Barrows et al. 2003). The literature supplied by the manufacturer of the scaffolds used in
the current study claim that they are 60% porous - similar to that of the scaffolds used in
the study by Lin et al.
4.2 Methods
4.2.1 Scaffold Preparation
Porous hydroxyapatite bone scaffold was obtained (Geistlich, Switzerland) and
tested in uniaxial unconfined compression. Five batches of Orthoss© scaffold, differing
only in chemical composition, were tested. The irregularly shaped samples were
machined to cubes of appropriate size for testing in the Dynastat. The as received
specimens were affixed to a precision-machined aluminum block with a small volume of
epoxy. The block was used both for holding the sample during the milling process and as
a reference surface. The irregularly shaped specimens were then milled to cubes
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approximately 6 mm on each edge. Care was taken to remove all the epoxy from the
specimen during the milling process. Any traces of epoxy that remained on the specimen
were restricted to a single face of the specimen and this face was positioned on the
bottom during the testing. Thus, if any epoxy remained in the scaffold after machining,
the reinforced face was not placed parallel to the direction of loading, where the
measurements could have been affected by the mechanical properties of the epoxy rather
than of the scaffold.
Figure 9. SEM of Orthoss scaffold (40x) from http://www.geistlich.com/biomaterials/en/ortho/index.html.
4.2.2 Dynastat Compression Protocol
After measuring the cross-sectional area with a micrometer, the dry scaffold
specimen was placed between two stainless steel platens mounted in the Dynastat
Mechanical Spectrometer (IMASS, Hingham, MA) at a separation of 10 mm. A 10 kg
load cell (Sensotec, Cleveland, OH) was fixed in the stationary upper platen and directly
coupled to the Dynastat.
The thickness of the specimen was measured by raising the Dynastat's bottom
platen (approximately 25 ptm/sec) until the load cell measured a 30 gram compressive
force; the distance between the platens at this nominal load was taken as the thickness of
the specimen.
The Dynastat was then programmed to compress the specimen at a rate of
approximately 2.5 pm/sec while force and displacement data were recorded at a sampling
rate of 0.1 / second. The 600 second compression was terminated at 25% engineering
strain (AL/Lo). The recorded force/displacement data were converted to engineering
stress/strain and plotted in EXCEL.
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4.2.3 Analysis of Dynastat Data
The linear elastic region was estimated visually from the stress-strain curve.
Typically, the linear region began after approximately 0.5-2.0% strain. This initial non-
linear region was assumed to be due to slight irregularities in the specimens' shape. The
linear region usually extended an additional 0.5-2.0%. A trend line was fitted to the
linear region from which the modulus (i.e., slope) and coefficient of determination were
recorded. In addition the ultimate compressive strength was noted. In several instances it
was not possible to measure an exact value for the ultimate compressive strength since it
exceeded the load cell's capacity. For such specimens the highest stress achieved before
exceeding the Dynastat's capacity was recorded.
4.2.4 Statistical Analysis
Data from all assays are reported as the mean (± SEM). Analysis of variance
(ANOVA) and Fisher's protected least squares differences (PLSD) post-hoc testing were
performed using StatView (SAS Institute Inc, Cary, NC). The criterion for statistical
significance was set at p = 0.05.
4.3 Results
The modulus, the coefficient of determination for the modulus, and the ultimate
strength values are listed in table 1 for all of the specimens tested. There was
considerable scatter in the data for both the ultimate strength and the modulus. Strength
measurements were further complicated by the fact that almost a third of the trials were
aborted before the ultimate strength was achieved due to loads exceeding the Dynastat's
limits.
Batch Sample Modulus (kPa) r2  Ultimate Strength (kPa)
1332 1 82.1 0.9803 4450
2 44.7 0.9770 750
3 41.8 0.9709 500
4 17.6 0.9666 450
5 20.7 0.9739 450
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1844 0.9683
6993 1 47.5 0.9637 800
2 90.2 0.9554 >1050
3 31.3 0.9249 500
4 58.7 0.9785 1100
5 121.5 0.9836 i950
6 27.4 0.9519 550
7093 1 102.6 0.9889 1550
2 109.0 0.9850 >1600
3 149.2 0.9310 >1600
4 85.1 0.9867 >1600
5 72.0 0.9602 850
6 113.6 0.9752 1500
7 68.0 0.9050 800
8 59.8 0.9412 800
7193 1 345.7 0.9554 >3400
2 181.9 0.9674 2400
3 75.7 0.9314 900
4 298.4 0.9349 >2300
5 177.1 0.9722 2200
6 221.9 0.9721 >2400
7 198.9 0.9670 >2000
7293 1 59.4 0.9189 900
2 72.8 0.9620 950
3 97.5 0.9757 >2200
4 123.6 0.9587 >2500
5 92.7 0.9724 1300
6 88.8 0.9483 1100
7 130.6 0.9705 1300
8 290-9 0.9655 >2500
Table 1. Modulus, coefficient of determination of modulus and ultimate strength values for non-hydrated
Orthoss samples tested in uniaxial, unconfined compression. Values with the strikethrough symbol were
deemed outliers according to the analysis described in the Results. Values with the "greater than" symbol
are the highest recorded values before the load cell limits were exceeded.
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Two different statistical approaches to data analysis were undertaken. In the first
approach, it was assumed that there were no outliers and all the data were included in the
ANOVA and post hoc tests. In the second approach, outliers (determined as described in
section 4.3.2) were culled from the data prior to performing the analyses.
4.3.1 Analysis of Entire Data Set
It was first assumed that all data were meaningful, and no outliers were removed
from the values. For those specimens whose ultimate strength could not be precisely
determined due to the limitations of the load cell, the highest recorded values for the
stress were taken as the ultimate strength; these values are preceded by the ">" symbol in
Table 1. The results of the strength measurements are indicated in the interaction bar plot
in Fig. 10, and the box plot in Fig. 11 gives some measure of the degree of scatter in the
data. The results of the modulus measurements appear in Fig. 12, and the box plot in Fig.
13 indicates the scatter in the modulus data.
ANOVA indicated both ultimate strength and modulus were significantly affected
by Orthoss batch (Fig. 10, p < 0.0019, power = 0.959 and Fig. 12, p < 0.0006, power =
0.986). Batch 7193 was significantly stiffer and stronger than all other batches. There
were no other statistically significant differences in the modulus measurements, although
the trend of the data suggests 1332 possessed the lowest modulus. A similar trend was
observed for the ultimate strengths. Batch 1332 had a lower ultimate strength (p =
0.0345) than 7293, but 1332 did not differ significantly in strength from 6993 or 7093.
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Figure 10. Average ( SEM) values for ultimate compressive strength of non-hydrated Orthoss specimens.
Outliers are not removed.
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Figure 11. Box plot for ultimate compressive strength of non-hydrated Orthoss specimens. Outliers are not
removed. The middle horizontal line is the median; the upper and lower ends of the notches are the 95%
confidence limit about the median; the upper and lower horizontal ends of the boxes are the 75t and 25t
percentile of observations about the median; and all dots beyond the extended lines represent observations
that are either in the top or bottom 10 percent.
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Figure 12. Average (± SEM) values for compressive moduli of non-hydrated Orthoss specimens. Outliers
are not removed.
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Figure 13. Box plot for compressive moduli of non-hydrated Orthoss specimens. Outliers are not
removed.
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4.3.2 Elimination of Outliers from Data
A simple statistical test was used to minimize the impact of outliers on the results.
To determine whether a particular value should be considered an outlier, the average and
standard deviation were calculated for all the measurements of the same type (i.e.,
modulus or compressive strength) and from the same batch (i.e., 1332, 6993, 7093, 7193,
and 7293) excluding the measurement in question. Then the value in question was
compared to the average value for that batch, and if it differed from the average by more
than three times the standard deviation, it was considered an outlier. The outliers are
indicated in the table by the strikethrough symbol superimposed on the value. For
example, in batch 1332 the modulus of sample 6 is an outlier since the average (±
standard deviation) modulus value for samples 1-5 was 41.4 (± 25.8) kPa, and as shown
below this average was greater than three sigma:
value - average value >? 3-
184.3 - 41.4 = 142.9 > 3 x 25.8
Therefore, only modulus values from samples 1-5 for batch 1332 were used in the
ANOVA and post hoc testing.
It is important to note regarding the analysis of the ultimate strengths that those
values that are preceded by the ">" symbol were ignored in the calculation of the average
and standard deviation. Thus, for example in batch 7193, the determination of outliers
was severely limited by the fact that four out of the seven data points were ignored since
no final values were recorded. After ignoring those four data points, the statistical test
indicated that the low data point was an outlier. Therefore, only two data points for 7193
were actually used in the inter-batch statistical comparison. The fact that the ultimate
strength values that were ignored for 7193 were all much higher than the 900 kPa value
substantiates the conclusion that this value is in fact abnormally low.
After the removal of outliers ANOVA indicated both ultimate strength and
modulus were significantly affected by Orthoss batch (Figs. 14 and 16, p < 0.0001, power
= 1.000). Batch 7193 was significantly stiffer and stronger than all other batches (p <
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0.0001). Although 1332 appeared to possess the lowest modulus (p = 0.0626 for 1332,
7093 andp = 0.0687 for 1332, 7293), these results did not achieve statistical significance.
However, 1332 did have the lowest ultimate strength (p = 0.0065 for 1332, 7093 andp
0.0058 for 1332, 7293).
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Figure 14. Average (± SEM) values for ultimate compressive strength of non-hydrated Orthoss specimens.
Outliers (greater than 3a, see description above) are not included.
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Figure 15. Box plot for ultimate compressive strength of non-hydrated Orthoss specimens. Outliers
(greater than 3a, see description above) are not included.
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Figure 16. Average (± SEM) values for compressive moduli of non-hydrated Orthoss specimens. Outliers
(greater than 3a, see description above) are not included.
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Figure 17. Box plot for compressive moduli of non-hydrated Orthoss specimens. Outliers (greater than 3a,
see description above) are not included.
4.4 Discussion
The high values for the coefficient of determination (0.91 - 0.99) confirmed that
the chosen strain region was highly linear.
The same trends were observed for both strength and modulus; in terms of
increasing values 1332 < 6993 < 7093 = 7293 < 7193.
By assigning the ultimate strengths for a number of the specimens to be equal to
the highest recorded value prior to overload, we have introduced artifacts to the statistical
analysis. First, we have in certain cases artificially lowered the apparent SEM. For
example, with batch 7093, we have assumed that three of the specimens had precisely the
same value for UTS, namely, 1600 kPa, whereas, it is highly unlikely that the true values
are so closely grouped. The effect of this artifact cannot be judged either uniformly
conservative or non-conservative. Such a determination will depend on what the other
values in the data set happen to be. Considering batch 7093 once again, we find that the
SEM of all eight UTS values is 138 kPa, while when the three approximated values are
removed from the data set, the SEM is 174 kPa. Thus, in the case of batch 7093 if we
remove the three values we are actually increasing the variability within that batch, so
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that it is less likely to appear to be significantly different from the other batches. This is
because the ANOVA and post hoc tests are sensitive to the variability within and between
batches. At the same time as we are increasing the variability (by removing the three
approximated values) we are reducing the mean UTS value from 1288 kPa to 1100 kPa.
Thus there is no simple method for determining which of the two methods is more
conservative.
Fortunately, both methods of analysis yield quite similar results. In fact the only
significant difference between the two methods is that when the outliers are removed the
UTS for 1332 is not different than that of 7093. Otherwise, the trends are the same, and
7193 is clearly stronger and stiffer according to either method of analysis.
In natural bone, there is a distinct orientation of the porous structure which has a
profound effect on the mechanical properties. It is as yet unclear whether the specimens
tested in the current study possess similar anisotropy. In these mechanical tests, no
attempt was made to orient the specimens with respect to the average axis of the pores.
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5. CONCLUSIONS
1. FGF Treatment (chapter 2)
a. Treating canine articular chondrocyte-seeded type II collagen-GAG scaffolds with
5 ng/ml fibroblast growth factor (FGF-2) does result in higher moduli after 28
days of culture when compared with untreated controls.
2. EDAC Cross-linking Treatment (chapter 2)
a. EDAC cross-linking increases the modulus of unseeded type II collagen-GAG
scaffolds exponentially with time as described (r2 = 0.74) by the kinetics equation
M(t) = 0.83 + 3.43*(1-e -/6. 07)
The non-EDAC treated scaffold stiffness of 0.83 kPa increased to 3.1 kPa (95%
c.i. of 2.7-3.5 kPa) after 10 minutes of EDAC cross-linking.
b. The kinetics data for the EDAC cross-linking indicate that 18 minutes of
treatment (i.e., approximately 3t) increased the intrinsic modulus to
approximately 95% of the maximum obtainable by this method, thus rationalizing
this as the optimum cross-linking treatment time.
3. Dynamic Compression (chapter 3)
These experiments were fraught with problems stemming from the unwitting use
of scaffolds with oversized pores. The large pore size (along with possible
decreased pore interconnectivity) rendered the scaffolds ineffectual in promoting
cell proliferation and ECM production.
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Definitive conclusions based on the current data are not warranted, but the
following observations are noted. GAG and DNA levels within the scaffolds
decreased substantially from 24 to 96 hours of dynamic compression, as expected
from reports in another similar study (Lee, Grodzinsky et al. 2003) which found
that in compressing the scaffolds, the DNA and GAG were expelled to the
medium. Radiolabel analysis indicated that essentially all of the newly
synthesized protein and GAG was found in the medium. There may have been
some increase in the modulus of the dynamically compressed (96 h) matrices, but
the low sample size (due to infections with many of the scaffolds, which in turn
was due to a loading chamber inadequate for long term compression studies)
makes it impossible to be certain.
4. Orthoss Mechanical Properties (chapter 4)
a. Chemical composition does affect the mechanical stiffness of bone scaffold
material. Differences in the scaffold composition (the details of which were
unavailable at the time of writing) and source (bovine vs. porcine) can be related
to both the modulus and the ultimate compressive strength.
b. Both modulus and ultimate strength were significantly affected by Orthoss batch.
Batch 7193 (labeled "spongiosa, porcine, loaded with collagen S" by the scaffold
manufacturer) was significantly stiffer and stronger than all other batches
regardless of which method of statistical analysis was employed. Batch 1332 (no
description available from the scaffold manufacturer) had the lowest ultimate
strength.
c. Given the impact of both density and trabecular orientation upon the mechanical
behavior, it would be useful in the future to correlate mechanical behavior with
these parameters.
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6. LIMITATIONS AND FUTURE WORK
The work presented in this thesis reveals the need for further efforts in each of the three
primary areas of investigation.
1. FGF treatment (chapter 2)
a. Repeat the experiment with a sufficient number of samples to perform
histology and biochemical assays (radiolabel, GAG and DNA). This will help
to determine the origin of the observed increase in scaffold modulus. Is it due
to increased ECM synthesis per cell, cellular proliferation (with unchanged
per cell synthesis rates) or something else?
b. Perform an in vivo study of FGF treated scaffolds in order to determine if they
reduce the pre-implantation time. Or, equivalently, how do treated and
untreated scaffolds (cultured for the same time prior to implantation) compare
(histologically, etc.) after a clinically relevant post-implantation period?
2. Dynamic compression (chapter 3)
a. Repeat experiments using scaffolds with a biologically active (- 90 pm) pore
size. Compare results with others who have used collagen-GAG scaffolds
(Lee, Grodzinsky et al. 2003) and hydrogel scaffolds (Mauck, Seyhan et al.
2002).
b. Retain media used during dynamic loading and measure DNA and GAG lost
from the scaffolds during loading.
c. Perform experiments that combine growth factors and dynamic loading to
determine whether a synergistic effect can be observed under the culture
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conditions employed in this experiment. Compare to work with other scaffold
materials (Mauck, Nicoll et al. 2003).
3. Orthoss mechanical properties (chapter 4)
a. Obtain SEMs of Orthoss specimens before and after machining to determine
whether microstructural cracks were formed as a result of machining.
Determine the effect of such cracks on mechanical properties.
b. Repeat the experiment using Orthoss specimens fabricated to a standard size
and shape appropriate for testing in the Dynastat so that no machining of the
specimens is required.
c. Repeat the experiments with smaller Orthoss samples, so that the capacity of
the load cell is not exceeded.
d. Perform the experiments with Orthoss specimens that have been hydrated in a
physiologically relevant solution.
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8. APPENDIX A
This appendix includes only those protocols that have been substantially changed
or clarified during the work described in this thesis. Standard protocols are collected in a
notebook in the orthopaedic research laboratory.
8.1 Serum-Free Chondrocyte Culture Media
8.1.1 Jakob Base Medium
*Used in both expansion and differentiation media
*Can be made in large batches (500 ml) and stored since it doesn't contain FBS
*All prices as of 10-28-03
1. 500 ml DMEM (high glucose: 4.5%) w/o L-Glutamin w/ Sodium Pyruvate (GIBCO
cat. no. 10313021, $16.40/bottle; this medium is not sold by the case)
2. 5 ml MEM Nonessential Amino Acids (NEAA) (10mM solution, GIBCO cat. no.
11140 050, $12.20)
3. 5 ml sterilized Hepes Buffer (IM solution, by GIBCO cat. no. 15630 056)
OR can make 1M solution w/ Hepes powder (238.3g/mol) in distilled water
(0.2383 g Hepes powder/ml dH2O-need to sterile filter)
4. 5 ml PSG contains 10000U/ml penicillin, 10000pg/ml streptomycin glutamate
(GIBCO, cat. no. 10378 016, $19.65/100 ml bottle)
8.1.2 Expansion Medium
*ADD growth factors at the last minute before use
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*Avoid repeated freeze-thaw cycles for all growth factors
1. 515ml of Jakob base media
2. 50 ml heat inactivated FBS or~ 0.1 ml FBS/ml of Jakob base (by GIBCO, cat. no.
16000 036, $81.44)
3. TGFP1- 1pI TGFP1 stock/ml media (1 ng TGFp1/mi
medium)
* Stock (1 tg TGFp /ml
buffer)
* Buffer
* Combine 2.5mg bovine serum albumin (BSA) + 0.lml 0.1N HCl** +
2.4ml H20 in 5ml centrifuge tube and vortex
Calculation: [(0.1ml of HCI) / (2.5 ml HCI+H 20)] x 0.1 moles HCI/liter = 4mM
* Sterile filter iml of the buffer and add 1Ig of TGFpl
* Aliquot 100pd stock/sterile 0.5ml eppendorf tube and store @ -70'C for three
months. TGFP 1 from R&D Systems, cat. no. 240-B-002 (for 2pg @ $245),
cat. no. 240-B-010 (10 pg @ $805)
**We have "HCl plus" that is 12.IN HCI, so add 0.5ml of 12.1N HCI + 60.5m] H 20 to get Q.N HCl
4. FGF-2 - 0.5p FGF-2 stock/ml media (5 ng FGF/ml medium)
* Stock (10 ptg FGF/ml
buffer)
* Buffer
* Combine 0.0025g BSA + 0.0004g DTT + 2.5 ml PBS in 5ml
centrifuge tube and vortex
* Sterile filter w/ syringe, and add to 25 pg of FGF-2
" Aliquot 100ptl stock/sterile 0.5ml eppendorf tube and store @ -70'C for three
months. FGF-2 from R&D Systems, cat. no. 233-FB-025 ($175/25 jg)
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5. PDGFP-- I pl PDGF stock/ml media (10 ng PDGF/ml media)
* Stock (10 ptg PDGF/ml
buffer)
" Buffer
* Combine 2.5mg BSA+ 0.1ml 0.iN HCl + 2.4ml H20 in 5ml
centrifuge tube and vortex
" Sterile filter iml of the buffer and add to 10ptg of PDGFPP
" Aliquot 100pjl stock/sterile 0.5ml eppendorf tube and store @ -70'C for three
months. PDGFp P from R&D Systems, cat. no. 220-BB-010 ($240/10ptg)
8.1.3 Differentiation Medium
*ADD supplements at the last minute before use:
1. 5Medium for differentiation:
2. 0015 ml Jakob base medium
DMEM
3. 5 ml MEM Nonessential Amino Acids (NEAA)
4. 5 ml Hepes Buffer
5. 5 ml PSG (penicillin, streptomycin and glutamate)
6.
7. --Above is the Jakob base media
8.
9. 5 ml ITS +1 Liquid Media Supplement (10OX), by SIGMA, cat. 12521
10. 5 ml STERILE human Serum Albumin solution (can useor BSA if not using
human cells-Atala protocol says to use 1.25mg BSA/ml of media) MUST
STERILE FILTER
11. FGF-2 - if desired
62
12. --Add ITS and BSA in correct amounts based on how much base media used (ie.
5mi per 515ml of Jakob base media
13.
14. TGFP1 - 10p TGFP1 stock/ml media (10 ng TGFI 1/ml
media)
!!Note that this is lOx the amount used in the expansion medium!!
15. Dexamethasone (DM) - 10d working solution/ml media (100 nM)
0 Dexamethasone (100 nM) water soluble (~65mg dexamethasone/gram of
powder-MW of dexamethasone = 392.5g/mol), by Sigma
S --+10 m of a 1/100 dilution of 10-3 M dexamethasone stock solution
* per ml of media
* Make 10-3 M dexamethasone (DM) stock in 100% ethanol (stable for 1
yr, stored @ -20*C) (Calc: iml 10-3 M DM x 0.001mol DM/1000ml x 392.5g
DM/lmol DM x ig powder/ 0.065g DM = 0.00603g powder -- in lml of ethanol)
0 Working solution: Make 10-5 M DM
* 20pil of 10-3 M DM stock + 1.98 ml LG-DMEM (low glucose!!)
* Stock: 10-3 M DM in 100% ethanol
* 6.03mg of DM powder per lml of 100% ethanol
Calculation: Iml 10-3 M DM x 0.001mol DM/1000ml x 392.5g DM/1mol DM x Ig powder/ 0.065g DM =
0.00603g powder -- in Iml of ethanol
* 10-5 M dexamethasone in low glucose DMEM (LG) by adding 20 l of 10-3 M
dexamethasone stock + 1.98 ml LG-DMEM
* Store in 100pl aliquots @ -20'C (stable for 1 yr)
-65mg DM/gram of powder
molec. wt. of DM = 392.5g/mol
Sigma
* Do not freeze/thaw cycle
6. L-Ascorbic acid 2-Phosphate - 10p stock/ml media (0.1 mM)
* -+ Stock: 37.5 mg ascorbate 2-phosphate + 10 ml Tyrodes solution
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* See Tyrodes salt preparation below
* Sterile filter the solution and store frozen (-20'C) in 2ml aliquots
* It is ok to freeze/thaw cycle
molec. wt. of 10D0m of a 1/100 dilution of ascorbate 2-phosphate = 289.54g/mol
Add 37.5 mg ascorbate 2-phosphate + 10 ml Tyrodes solution
+ Tyrodes solution is made from Tyrodes salts and prepared following the instructions
that camame w/ the Tyrodes bottle. For preparation of 1 00ml of Tyrodes solution:
" Add lg of Tyrodes salt + 90ml of dH 20 (15-20*C)-gently stir the water
while adding salt until completely dissolved.
" Add 0. 1g sodium bicarbonate or 1.33 ml of sodium bicarbonate solution
(7.5%w/v) for each liter of final volume of medium being prepared (i.e. 0.Olg
sodium bicarbonate for 100ml of Tyrodes solution). Stir until dissolved.
" While stirring, adjust the pH of the medium to 0.1-0.3 pH units below the
desired pH (8.0) since it may rise during filtration (desired pH is 8.0) using 1N
HCl or 1N NaOH.
* Add additional water to bring the solution to the final volume (i.e., 100ml).
" Sterilize immediately using a 0.22 pm filter.
* Double check pH of the solution each time solution is used.
" Store the dry powdered salts at 2-8*C under dry conditions and liquid medium
at 2-8*C in the dark.
* Discard dry salt if there is a color change, granulation! clumping, or
insolubility. Liquid mediumDiscard solution if there is a pH change, precipitate
or particulate matter throughout the solution, cloudy appearance, or a color
change.
Sterile filter the ascorbate 2-phosphate solution and store frozen (-20*C) in 2ml aliquots
* To passage cells, before trypsinization, incubate cells with STERILE FILTERED
solution of 0.15% collagenase type 2 in PBS for -5 minutes (i.e., 0.0015 g
collagenase/ml PBS). Some cells will detach and float in the PBS. Pipet out the PBS
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into a centrifuge tube and save. Add trypsin to flasks and incubate for 5 min.
Deactivate the trypsin by adding medium WITH FBS and transfer the medium +
trypsin + cells to the centrifuge tube with the PBS/collagenase solution. Spin down
and remove the supernatant. Resuspend in medium with FBS. Spin down and
remove the supernatant. Resuspend in a volume of SERUM-FREE Jakob base
medium convenient for counting.
8.1.4 The Short List Of Media Ingredients
8.1.4.1 Base Medium
500 ml DMEM (high glucose)
5 ml MEM Nonessential Amino Acids
5 ml sterile Hepes Buffer
5 ml PSG
8.1.4.2 Expansion Medium
515ml of Jakob base
50 ml FBS or ~ 0.1 ml FBS/ml of Jakob base
1l TGF pl stock/ml media
0.5pl FGF-2 stock/ml media
1 pl PDGF stock/ml media
8.1.4.3 Differentiation Medium
5Medium for differentiation:
0015 ml Jakob base DMEM
5 ml MEM Nonessential Amino Acids (NEAA)
5 ml Hepes Buffer
5 ml PSG (penicillin, streptomycin and glutamate)
--Above is the Jakob base media
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5 ml ITS or 10pl ITS/ml media
5 ml can useBSA or 10p BSA/ml media
--Add ITS and BSA in correct amounts based on how much base media used (ie. 5ml per
515ml of Jakob base media
1 Op TGFp 1 stock/ml media
1 Opl working dexameth. soln/ml media
1 Opl L-Asc. acid 2-Phosphate stock/ml media
FGF-2 - if desired
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8.2 Scintillation Counting of Radiolabeled Matrices
(from C. Lee's dissertation Appendix E.5, modified by T. Gordon 4-27-04)
8.2.1 Summary
Radioactive counts of matrix digests and calibrated medium are measured with the Rack-
Beta 1211, LKB (Turku, Finland) liquid scintillation counter.
8.2.2 Protocol
Combine 100 pl of sample digest or calibrated medium with 2 ml of scintillation fluid
(CytoScint ES, ICN Biomedicals Inc., Irvine, CA). If the counts are too low or high, you
may have to add more or less than 100 p1 of digest; make up the balance with dH2 0.
Counts per minute (cpm) were measured with the Rack-Beta 1211, LKB (Turku, Finland)
liquid scintillation counter in the 3 rd floor of the Biomedical Research Department at 500
Tech Square, Cambridge, MA.
Channel 1 (also referred to as channel A) recorded activity from 0.5 - 18.6 keV, channel
2 (or, channel B) recorded activity from 18.6 - 156 keV and the machine counted for 3
minutes/sample (or less if it determines accuracy to 2y before this period). After
determining the spillover correction constants (discussed below), the cpmA and cpmB
can be converted to nanomoles of incorporated radiolabel.
Quenching effects were assumed to be constant throughout all measurements and were,
therefore, not directly treated in the calculations.
After samples are counted, the vials with scintillation fluid and radioactive digest should
be dumped into the barrel for liquid scintillation vials.
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8.2.3 Theory
It is not possible to isolate all the counts for both radionuclides into separate channels
when counting a dual-labeled sample, since the energy vs. cpm curve for the
radionuclides will overlap. However, it is possible to isolate tritium. The maximum
energy of 3H counts is 18.6 keV, so by setting the upper limit of channel I to this value,
all 3H counts will occur in channel 1 and none will spill over into channel 2. The lower
limit of channel 1 is set at 0.5 keV to eliminate any low energy noise. Unfortunately, 35S
counts extend from 0 to 167 keV, so some of the counts in channel 1 will be due to S
and some will be due to 3H.
In general, when there is spillover of counts from both radionuclides into the channels of
each other, four constants are necessary to determine the concentrations 3H and 3 5S.
These constants can be thought of as the instrument's counting efficiencies for the two
isotopes in the two different energy regions. Two of the constants give the percentages of
cpmA and cpmB values due to 3H. The other two constants give the percentages of
cpmA and cpmB values due to 35S. In the calculations, the constants are defined as
follows:
k, = % cpm in channel 1 from 3IH, not 35 S.
k12 = % cpm in channel 2 from 3H, not 35 S.
k21 = % cpm in channel 1 from 35 S, not 3H.
k22 = % cpm in channel 2 from 35S, not 3H.
8.2.4 Calculations
8.2.4.1 Calculating the Counting Efficiency Constants
The concentration of 3H and 35S is directly proportional to the amount of radioactivity (as
indicated by the measureable radioactive decay) in the matrix digests. These
concentrations may be expressed as a function of the cpm from channels A and B (i.e., C1
and C2 ) as follows:
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[IHI ] 'ki k12C
s] (kal k22 C2
From the first vial (containing 3S only, no 3H), the equation becomes:
0 = kjCs + k2C2
[3 5S] =k C 2 1 1 + k 22 C2
where [35 S] indicates the concentration of 3S added to media; superscript "S" indicates
that counts are from first media sample with 35S only, subscripts denote the channel
counted. The fact that there is no tritium in the first vial (or at least there shouldn't be
any if you followed the radiolabeling procedure correctly) is reflected by the zero in the
first of the above pair of equations.
From the second vial (conaining both 35S and 3H), the appropriate equations are:
[3 H] = kICsH+ k1 2 C2,H
[ 35S] = k21CIS" + k2C,H
where [35 S] and [3H] indicate the concentrations of 35sS and 3H, in ptCi/ml, added to the
medium, respectively; superscript "S,H" indicates that counts are from the second vial,
containing both 35S and 3H; subscripts denote the channel counted.
Solving these 4 equations for the 4 unknown k's:
69
11 C ['H]kiC -kSH S
kIS =k=CIS,H 
H S
C2
k- [3H]
12 CS,H C S 2
CSH _ C1 2C
CIS
k= 35SC 
SH
2 C1SHC% H - CI
I [35Si(cCI S~ -I)S =CIS,H 
_ CSH
8.2.4.2 Calculating the Radioactive Proline and Sulfate Concentrations
in the Samples
By using these four constants and the counts per minute for channels 1 and 2 for each
sample, you can determine the concentration of radioactive proline and sulfate in the
sample. For example, if one of your samples produces a cpmA value of 1000 and cpmB
value of 3000, then the radioactive proline and sulfate concentrations for that sample are
[3H]=1000 -(k] )+ 3000 -(k12 )
[35S] =1000 (k )+3000. (k22 ).
In order to get the actual values, substitute the values of the four constants found in
section A of these instructions into the expressions above.
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8.2.4.3 Calculating the Fractions of Available Proline and Sulfate
Incorporated into the ECM
The percentage of the total available radiolabeled proline incorporated into the protein
manufactured during the radiolabeling period ccproiine is given by the ratio of the
radioactive proline concentration in the digested sample (found in part B, above) to the
proline concentration of the medium (the known amount of radioactive proline you added
to the medium, usually in piCi/ml). The calculation for asulfate is analogous. The
expressions for these fractions are
Ciki I + C2k12
a praline [ ClH]~ 1
a Ck +C 2 k2 2asulffate 
I5
Next, we assume that the same percentage of radiolabeled proline/sulfate and unlabeled
proline/sulfate were incorporated into the ECM by the cells. This makes sense since if
there are 1000 molecules of unlabeled proline in the medium and only 10 molecules of
labeled proline and the cells use 101 molecules of proline total, they will use 100
molecules of unlabeled proline and 1 molecule of labeled proline. In other words, the
only reason there is more unlabeled proline incorporation is because the actual number of
available unlabeled molecules of proline is greater than the number of labeled molecules.
But the percentage of radiolabeled and unlabeled molecules is the same because the cells
do not inherently prefer one over the other:
(100 unlabeled molecules used) / (1000 unlabeled molecules available) = (1
labeled molecule used) / (10 labeled molecules available) = 10% of available
molecules used
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Furthermore, assume that the amount of proline/sulfate added in radiolabeled form is
insignificant compared to the concentrations of unlabeled proline/sulfate in the medium.
Strictly speaking, the total number of moles of proline/sulfate incorporated into the ECM
is the sum of the radiolabeled proline/sulfate and the unlabeled proline/sulfate, but if you
assume the labeled molecules are negligible, you can ignore their contribution to the total
number of moles of incorporation. Then the proline/sulfate incorporation is due only to
the unlabeled proline/sulfate taken out of the medium by the cells in order to synthesize
collagen and proteoglycans, respectively. The following calculation demonstrates the
validity of the assumption that the amount of added radiolabeled proline/sulfate is
insignificant compared to the concentrations of unlabeled proline/sulfate present in the
medium: one recent bottle of proline had 31 Ci/mmol and the concentration of
radioactive proline in the culture medium was [3H] = 10 ptCi/ml, so the molarity of
radioactive proline in the medium is
l0xl- 6 Ci /ml
= 3.2x10- mmol / ml = 0.32nmol / ml .
31Ci /mmol
This molarity value is much lower than the 150 nmol/ml proline in DMEM/F12 medium
(this value is from the manufacturer's data sheet on the contents of DMEM/F12). The
situation is similar for sulfate: there is 406 nmol/ml of unlabeled sulfate in DMEM/F12
medium.
IMPORTANT NOTE: if you use any medium other than DMEM/F12 during the
radiolabeling period, you must look up the proline and sulfate molar concentrations for
all of the components of that medium and add them together (multiplying each
component by its volume fraction in the medium) to get the actual values for your
calculations. For example, the non-essential amino acids (NEAA) used in the Jakob
media has proline in it. You cannot use the values of 150 nmol/ml proline and 406
nmol/ml sulfate unless the only proline and sulfate containing ingredient in your media is
DMEM/F12. Other media formulations will require different numbers. However in the
calculations below I have used those values as an example. I have also assumed that 88%
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of the volume of the medium was due to the DMEM and 12% of the medium was due to
other ingredients which did not contain any proline of sulfate.
The amount of proline/sulfate incorporated into macromolecular form during the
radiolabel period is then determined as follows:
moles ofproline =V-aproine (0.88) - (150 nmol/ml)
moles of sulfate = V asulfate (0.88) -(406 nmol/ml)
where V is the volume of radiolabeled media fed to the cultures, in milliliters.
Incorporation data can be normalized to the time of radiolabel and the amount of DNA in
the matrix to yield the rate of incorporation normalized to cell content (nmol/ptg
DNA/hr).
For the Jakob serum-free media formulation the high-glucose DMEM (GIBCO cat. no.
10313021) contains 97.67 mg/L of magnesium sulfate (molec. wt. = 120.37 g/mol) =
8.11 x10-4 M. Approximately 95% of the differentiation medium is DMEM, so there is
7.71 x10-7 mol/L = 771 nanomoles of sulfate per ml of differentiation medium.
Similarly, the l00x NEAA (10mM solution, GIBCO cat. no. 11140 050) contains 1150
mg/L of proline (molec. wt. = 115.13 g/mol) = 0.01 M. But only 0.95% of the
differentiation medium is DMEM, so there are 0.95 x10-4 mol/liter = 9.5 x10-8 mol/L = 95
nanomoles of proline per liter of differentiation medium. Thus with the Jakob media
the amount of proline/sulfate incorporated into macromolecular form during the
radiolabel period is
moles ofproline = V -aproine - (95 nmol/ml)
moles of sulfate = V -asufae - (771 nmol/ml)
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where V is the volume of radiolabeled media fed to the cultures, in milliliters. There is
no proline or sulfate in any other Jakob media components.
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9. APPENDIX B
This appendix includes data for the modulus vs. cross-linking time and modulus
of FGF- and non-FGF treated scaffolds shown in Fig. 1 and 3 in chapter 2 of this thesis.
9.1 Modulus vs.EDAC Cross-linking Time (chap. 2.3.1)
cross-link time (min)
0
0
10
10
10
5
5
10
10
10
60
60
60
120
120
120
modulus (kPa)
0.8304
1.0071
1.8691
1.7929
2.4242
2.4832
2.4947
4.7958
2.3142
3.4156
4.7202
3.9748
3.7239
3.4916
5.3429
4.5583
9.2 Modulus of FGF- and non-FGF Treated Scaffolds After Four Weeks
of Incubation (chap. 2.3.2)
modulus (kPa)
unseeded control FGF
3.098 4.134 8.440
3.885 4.593 16.497
2.906 6.741 8.842
2.899 11.367 25.465
2.661 17.169 27.794
cells
A
B
C
D
E
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